CHICAGO--(BUSINESS WIRE)--Pathos AI, Inc. (“Pathos”) today announced that it has, through its wholly owned subsidiary WK Merger Sub, Inc. (“Merger Sub”), successfully completed its tender offer to ...

London‑listed PRTech firm Pathos Communications has developed its proprietary AI platform, PathosMind. Designed exclusively for use by Pathos employees and partners, it surfaces stories that genuinely ...

Pathos AI has secured $365 million in a series D raise as the artificial-intelligence-powered biotech looks to fund trials of solid tumor drugs sourced from Novo Nordisk and Prelude Therapeutics. The ...

Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, today announced that it has raised $365 million in a late-stage funding. The company didn’t disclose the ...

Pathos Communications (LSE:NEWS) is a technology-enabled, human-led PR company, which has been ranked as the fastest growing advertising and marketing company in the UK by the Financial Times 1000.